spacer
home > pmps > summer 2017 > factory of the future
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Factory of the Future

Despite strict administrative regulations, the pharmaceutical sector is an increasingly competitive marketplace where established industry giants are vying against providers of cheaper, generic alternatives. Meanwhile, new companies – formed through merger and acquisition activities – are approaching the field.

Existing players are under increasing pressure. Delivering the highest quality products and accurate information on packaging is now more critical than ever before. Medications need to not only appeal to the consumer with clear guidelines on safe use, ingredients and side effects, but must also be compliant with the rigorous stateimposed standards.

Every package must contain accurate data and clear labelling before it can be distributed to healthcare and pharma organisations en masse. Given the unique regulations surrounding the sale of therapeutics and similar medical products compared to other goods, drug developers are required to take special care on their production lines, while keeping operational costs low.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Eva Weber, Senior Product Marketing Manager for SDKs, is responsible for product marketing activities for ABBYY Europe’s technology licensing products. With her extensive expertise, Eva is a key driver of the company's activities around the usage of OCR within the machine vision industry, including educational webinars and press articles. 
spacer
Eva Weber
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

ICON Announces Executive Leadership Transition


More info >>

White Papers

pAVEway™ expression system for the efficient expression of therapeutic proteins

Fujifilm Diosynth Biotechnologies

One of the major bottlenecks in the production of biopharmaceuticals is the efficient expression of therapeutic proteins in microbial or mammalian cells. The Escherichia coli pAVEway™ expression system described here has been developed to ensure high product titres and efficient scale up to GMP manufacture, whilst minimising many common issues seen in other expression systems, such as ‘leaky’ expression (expression of recombinant protein in the absence of inducer).
More info >>

 
Industry Events

PREP 2018: 31st International Symposium and Exhibit on Preparative and Process Chromatography

8-11 July 2018, Hyatt Regency in the Baltimore Inner Harbor, MD, USA

The PREP series of symposia is the most recognized international conference devoted to advances in separation technologies in the field of preparative and process chromatography. Join us for a dynamic and innovative program where experts from around the world will address the latest developments and hottest topics in preparative and process chromatography.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement